<DOC>
	<DOCNO>NCT02669758</DOCNO>
	<brief_summary>The primary objective study evaluate long term safety tolerability ALKS 3831 subject schizophrenia .</brief_summary>
	<brief_title>A Long-Term Safety Tolerability Study ALKS 3831 Adults With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Subject complete 4week treatment period ( visit include end treatment visit ) antecedent study ALK3831A305 within 7 day . Agrees use acceptable method contraception duration study . Additional criterion may apply . Subject currently take medication contraindicate olanzapine use . Subject positive test drug abuse study entry . Subject pregnant , plan become pregnant , breastfeed study . Additional criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Alkermes</keyword>
	<keyword>ALKS 3831</keyword>
	<keyword>Samidorphan</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Safety</keyword>
</DOC>